A trend solidified in 2022: suppliers are betting on M&A while OEMs disinvest and spin-off.

Katie Hobbins, Managing Editor

January 25, 2023

9 Slides

Over 2022 and into January of this year, a trend has solidified. Medtech suppliers are merging into larger companies, while OEMs downsize and spin-off business units. Here are some of the biggest supplier M&A and OEM spin-offs MD+DI reported on.

About the Author(s)

Katie Hobbins

Managing Editor, MD+DI

Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like